19 Oct 2018 12:10
EKF Diagnostics Holdings plc
("EKF", the "Company")
Result of General Meeting
EKF Diagnostics Holdings plc (AIM: EKF), the AIM quoted medical diagnostics business, announces that at the General Meeting held earlier today, the resolution to approve a distribution of the Company's shareholding in Renalytix AI plc to the Company's shareholders was duly passed. This enables the Directors to proceed to finalise the necessary arrangements to give effect to the distribution.
Further announcements will be made in due course.
EKF Diagnostics Holdings plc | www.ekfdiagnostics.com |
Christopher Mills, Non-Executive Chairman | Tel: 029 2071 0570 |
Julian Baines, CEO | |
Richard Evans, FD & COO | |
N+1 Singer (Nomad & Broker) | Tel: 020 7496 3000 |
Aubrey Powell / Lauren Kettle / George Tzimas | |
Walbrook PR Limited | Tel: 020 7933 8780 or ekf@walbrookpr.com |
Paul McManus / Lianne Cawthorne | Mob: 07980 541 893 / 07584 391 303 |
Ekf Diagnostics (EKF)